Stick with Emerging Markets, McKinsey's Bhadoria Tells Pharma
This article was originally published in Scrip
Executive Summary
Vikas Bhadoria, director, McKinsey & Company, suggests that pharma should ride through turbulence in some of the "fundamentally strong" but currently challenging emerging markets, risk mitigation approaches in tow.